# Life Sciences AI Academy

## Enterprise AI Training Program Review

Template version: 1.0 | Prepared: 11 November 2026

Organization: ____________________
Review scope and systems: ____________________
Review owner and participants: ____________________
Review date: ____________________

Use this illustrative worksheet with Quality, training, process and system owners. Record evidence and an action owner for each gap. Company approval is required before incorporating this worksheet into a controlled process. Compliance, system validation and task qualification require their own company decisions.

Status choices: Evidence available; Partial evidence; Action needed; Not reviewed. Where an item falls outside scope, document the rationale.

### Define the scope and accountable owners

**1. Have we documented which requirements and internal controls apply to the AI uses in scope?**

Evidence to review: A dated applicability review using current primary sources, with jurisdiction, final or draft status, rationale, reviewer and a review trigger.

Status: ____________________
Evidence reference and version: ____________________
Gap or scope rationale: ____________________
Action and acceptance criteria: ____________________
Owner and due date: ____________________
Closure evidence and reviewer: ____________________

**2. Does our inventory cover the AI used in our work, including embedded features and relevant supplier use?**

Evidence to review: A current register showing system, intended use, process, affected records or decisions, owner and unresolved inventory gaps.

Status: ____________________
Evidence reference and version: ____________________
Gap or scope rationale: ____________________
Action and acceptance criteria: ____________________
Owner and due date: ____________________
Closure evidence and reviewer: ____________________

**3. Are responsibilities and potential GxP consequences clear for each use case?**

Evidence to review: An accountable-owner map, documented provider or deployer responsibilities where relevant, and an impact rationale addressing patient safety, product quality and data integrity.

Status: ____________________
Evidence reference and version: ____________________
Gap or scope rationale: ____________________
Action and acceptance criteria: ____________________
Owner and due date: ____________________
Closure evidence and reviewer: ____________________

### Assign learning to actual work

**4. Do learning assignments reflect each person's systems, tasks, access and decision authority?**

Evidence to review: A role-to-system matrix reconciled with access lists and workflow responsibilities, including people who perform multiple roles.

Status: ____________________
Evidence reference and version: ____________________
Gap or scope rationale: ____________________
Action and acceptance criteria: ____________________
Owner and due date: ____________________
Closure evidence and reviewer: ____________________

**5. Have we covered employees, contractors and relevant personnel working on our behalf?**

Evidence to review: Defined learner populations, training responsibilities, onboarding and offboarding controls, and an owner for coverage gaps.

Status: ____________________
Evidence reference and version: ____________________
Gap or scope rationale: ____________________
Action and acceptance criteria: ____________________
Owner and due date: ____________________
Closure evidence and reviewer: ____________________

**6. Are learning outcomes observable, with prerequisites and access decisions defined?**

Evidence to review: Task-specific outcomes, required learning, an assessment method and the company-approved process for access, supervision and task authorization.

Status: ____________________
Evidence reference and version: ____________________
Gap or scope rationale: ____________________
Action and acceptance criteria: ____________________
Owner and due date: ____________________
Closure evidence and reviewer: ____________________

### Develop, deliver and assess the training

**7. Does system training explain the approved purpose, limitations, data boundaries and escalation route?**

Evidence to review: Reviewed system-specific materials linked to the applicable procedure, including examples of permitted use, prohibited use and when to stop.

Status: ____________________
Evidence reference and version: ____________________
Gap or scope rationale: ____________________
Action and acceptance criteria: ____________________
Owner and due date: ____________________
Closure evidence and reviewer: ____________________

**8. Are content, delivery responsibilities and training records controlled?**

Evidence to review: Approved material versions, qualified or otherwise approved facilitators under the local process, delivery records and defined retention requirements.

Status: ____________________
Evidence reference and version: ____________________
Gap or scope rationale: ____________________
Action and acceptance criteria: ____________________
Owner and due date: ____________________
Closure evidence and reviewer: ____________________

**9. Can reviewers demonstrate that they detect and handle material AI errors?**

Evidence to review: Known-error practice cases, source-verification exercises, scoring criteria, critical-error rules, remediation and a documented reassessment decision.

Status: ____________________
Evidence reference and version: ____________________
Gap or scope rationale: ____________________
Action and acceptance criteria: ____________________
Owner and due date: ____________________
Closure evidence and reviewer: ____________________

### Maintain performance and supplier oversight

**10. Have relevant supplier AI use and training responsibilities been addressed in oversight arrangements?**

Evidence to review: Risk-based supplier questions, evidence requests and applicable contractual or quality-agreement responsibilities, including change notification and subcontractor coverage.

Status: ____________________
Evidence reference and version: ____________________
Gap or scope rationale: ____________________
Action and acceptance criteria: ____________________
Owner and due date: ____________________
Closure evidence and reviewer: ____________________

**11. Do we review whether people apply the training effectively in the actual workflow?**

Evidence to review: An agreed approach to observed practice or sampled work, recurring-error review, reviewer performance, escalation trends and follow-up actions.

Status: ____________________
Evidence reference and version: ____________________
Gap or scope rationale: ____________________
Action and acceptance criteria: ____________________
Owner and due date: ____________________
Closure evidence and reviewer: ____________________

**12. Does change control assess the effect of system and process changes on training?**

Evidence to review: Recorded training-impact decisions for model, feature, intended-use, role and procedure changes, with revised materials and retraining where justified.

Status: ____________________
Evidence reference and version: ____________________
Gap or scope rationale: ____________________
Action and acceptance criteria: ____________________
Owner and due date: ____________________
Closure evidence and reviewer: ____________________

### Make evidence and decisions reviewable

**13. Can we distinguish attendance and completion from demonstrated performance and work authorization?**

Evidence to review: Records identifying the learner, material version, assessment scope, result, remediation and the separate company qualification or access decision.

Status: ____________________
Evidence reference and version: ____________________
Gap or scope rationale: ____________________
Action and acceptance criteria: ____________________
Owner and due date: ____________________
Closure evidence and reviewer: ____________________

**14. Can we retrieve a coherent program evidence package within a defined internal target?**

Evidence to review: A retrieval exercise covering the inventory, rationale, assignments, materials, assessments, exceptions and maintenance records, with an owner for missing evidence.

Status: ____________________
Evidence reference and version: ____________________
Gap or scope rationale: ____________________
Action and acceptance criteria: ____________________
Owner and due date: ____________________
Closure evidence and reviewer: ____________________

**15. Does an accountable sponsor review gaps, effectiveness and continued fitness of the program?**

Evidence to review: A documented periodic review, accepted actions with owners and due dates, resource decisions and the next review date or trigger.

Status: ____________________
Evidence reference and version: ____________________
Gap or scope rationale: ____________________
Action and acceptance criteria: ____________________
Owner and due date: ____________________
Closure evidence and reviewer: ____________________

## Review disposition

Priority actions: ____________________
Open issues and interim controls: ____________________
Sponsor decision and reviewer: ____________________
Next review date or trigger: ____________________

This worksheet supports structured review and planning. Apply your organization's document control, retention and approval requirements. Retrieval targets and retraining decisions are defined through the applicable company process.

Service model: https://lifesciencesai.academy/enterprise-ai-training
European Commission reference: https://digital-strategy.ec.europa.eu/en/library/living-repository-foster-learning-and-exchange-ai-literacy
